Ladenburg, Germany

Michael Kulke

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Ludwigshafen, DE (2008 - 2023)
  • Ladenburg, DE (2021 - 2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Michael Kulke: Innovator in Pharmaceutical Conjugates

Introduction

Michael Kulke is a prominent inventor based in Ladenburg, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of antibody conjugates. With a total of 10 patents to his name, Kulke's work focuses on innovative solutions for treating immune cell-related diseases.

Latest Patents

Among his latest patents, Kulke has developed B-lymphocyte specific amatoxin antibody conjugates. This invention relates to conjugates that comprise an amatoxin and a target-binding moiety, specifically targeting CD37. The synthesis of these conjugates is a key aspect of his work, which also includes pharmaceutical compositions for treating B-cell and lymphoma-associated diseases. Another notable patent involves amanitin conjugates, which consist of an amatoxin with specific amino acid modifications, a target-binding moiety, and optionally a linker. This invention also extends to pharmaceutical compositions that utilize these conjugates.

Career Highlights

Throughout his career, Michael Kulke has worked with notable companies in the pharmaceutical sector, including Heidelberg Pharma Research GmbH and Heidelberg Pharma GmbH. His expertise in the field has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Kulke has collaborated with esteemed colleagues such as Torsten Hechler and Werner Simon, further enhancing the impact of his work in the industry.

Conclusion

Michael Kulke's innovative contributions to pharmaceutical conjugates demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological interactions and a dedication to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…